PLIR Advisory Board Sees Biosimilars, Enforcement Among Top Concerns for 2011
BNA's Pharmaceutical Law & Industry 1/21/2011
On January 21, 2011, BNA's Pharmaceutical Law & Industry quoted Mintz Levin attorney Linda Bentley in an article entitled, "PLIR Advisory Board Sees Biosimilars, Enforcement Among Top Concerns for 2011."